Am Heart J
- KRUCOFF M, Spirito A, Baber U, Sartori S, et al
Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention
in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup
analysis of the TWILIGHT randomized clinical trial.
Am Heart J. 2024 Mar 6:S0002-8703(24)00053-X. doi: 10.1016/j.ahj.2024.
Am J Cardiol
- DHALIWAL JS, Kumar N, Mactaggart S, Sakthivel H, et al
Cardiovascular complications in young adults with Post-Acute Sequelae of
COVID-19: a perspective from the United States.
Am J Cardiol. 2024 Mar 11:S0002-9149(24)00164.
- O'BRIEN JM, Dinh D, Roberts L, Teh A, et al
Associations Between Metabolic Syndrome and Long-Term Mortality in Patients who
underwent Percutaneous Coronary Intervention: An Australian Cohort Analysis.
Am J Cardiol. 2024 Mar 4:S0002-9149(24)00146.
Am J Med
- FREUND O, Shetrit A, Bar-Shai A, Zornitzki L, et al
Smoking and respiratory diseases in patients with coronary microvascular
dysfunction.
Am J Med. 2024 Mar 12:S0002-9343(24)00134-7. doi: 10.1016/j.amjmed.2024.
Angiology
- GIANNAKOPOULOU SP, Antonopoulos A, Panagiotakos D
Serum Inflammatory Markers Used in Cardiovascular Disease Risk Prediction Models:
A Systematic Review.
Angiology. 2024 Mar 14:33197241239691. doi: 10.1177/00033197241239691.
- WANG K, Wang W, Niu J, Liu X, et al
Elevated Plasma Lipoprotein(a) Level and Atherosclerotic Cardiovascular Disease
Risks: A Large Clinical Retrospective Study.
Angiology. 2024 Mar 13:33197241239688. doi: 10.1177/00033197241239688.
- JIAN W, Shen X, Zheng Z, Wu Z, et al
Association Between Red Blood Cell Distribution Width and Coronary Calcification
in Patients Referred for Invasive Coronary Angiography.
Angiology. 2024 Mar 11:33197241238509. doi: 10.1177/00033197241238509.
Atherosclerosis
- HAKAMAA E, Goebeler S, Martiskainen M, Louhelainen AM, et al
Sex differences in coronary atherosclerosis during the pre- and postmenopausal
period: The Tampere Sudden Death Study.
Atherosclerosis. 2024;390:117459.
- GRINBERG T, Eisen A, Talmor-Barkan Y, Kornowski R, et al
Novel plasma biomarkers of coronary artery calcium incidence or progression:
Insights from the prospective multi-ethnic Dallas Heart Study cohort.
Atherosclerosis. 2024;390:117469.
- SCHLEGEL A
Diagnostic challenge of an APOB variant of uncertain significance resolved by
transheterozygosity with a pathological LDLR variant and clinical response to
therapy.
Atherosclerosis. 2024;390:117460.
- CHEDID G, Malik A, Daher R, Welty FK, et al
Reply to: "Comments on "Higher exercise capacity, but not omega-3 fatty acid
consumption, predicts lower coronary artery calcium scores in women and men with
coronary artery disease"".
Atherosclerosis. 2024;390:117452.
- KHAN SU, Al-Mallah MH
Air pollution and acute coronary syndrome: The air we breathe.
Atherosclerosis. 2024;390:117453.
- GU SZ, Ahmed ME, Huang Y, Hakim D, et al
Comprehensive biomechanical and anatomical atherosclerotic plaque metrics predict
major adverse cardiovascular events: A new tool for clinical decision making.
Atherosclerosis. 2024;390:117449.
- FISHBEIN I, Inamdar VV, Alferiev IS, Bratinov G, et al
Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the
mitigating effect of stent surface modification with a CD47-derived peptide.
Atherosclerosis. 2023;390:117432.
- CENKO E, Manfrini O, Bugiardini R
Net adverse clinical events with P2Y(12) inhibitor therapy in older patients
after percutaneous coronary interventions.
Atherosclerosis. 2024;390:117434.
- ZHANG D, Li P, Qiu M, Liang Z, et al
Net clinical benefit of clopidogrel versus ticagrelor in elderly patients
carrying CYP2C19 loss-of-function variants with acute coronary syndrome after
percutaneous coronary intervention.
Atherosclerosis. 2023 Dec 13:117395. doi: 10.1016/j.atherosclerosis.2023.117395.
- ASMARIAN N, Raeisi Shahraki H
Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption,
predicts lower coronary artery calcium scores in women and men with coronary
artery disease".
Atherosclerosis. 2024;390:117426.
- RINALDI R, Russo M, Bonanni A, Camilli M, et al
Short-term air pollution exposure and mechanisms of plaque instability in acute
coronary syndromes: An optical coherence tomography study.
Atherosclerosis. 2024;390:117393.
BMJ
- TANNE JH
Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
BMJ. 2024;384:q642.
Cardiovasc Res
- ABOULEISA RRE, Tang XL, Ou Q, Salama AM, et al
Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure
in rats.
Cardiovasc Res. 2024 Jan 4:cvae002. doi: 10.1093.
Circ Cardiovasc Imaging
- BITTENCOURT MS
Prognostic Value of Coronary Atherosclerotic Burden, Its Plaque Components and
Estimation of Coronary Flow by Coronary Computed Tomography.
Circ Cardiovasc Imaging. 2024 Mar 12:e016524.
Circ Cardiovasc Interv
- DAWSON LP, Rashid M, Dinh DT, Brennan A, et al
No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary
Intervention: The NORPACS Risk Score.
Circ Cardiovasc Interv. 2024 Mar 15:e013738.
Circ Res
- LO EH, Faraci FM
Circadian Mechanisms in Cardiovascular and Cerebrovascular Disease.
Circ Res. 2024;134:615-617.
- LAL H, Verma SK, Wang Y, Xie M, et al
Circadian Rhythms in Cardiovascular Metabolism.
Circ Res. 2024;134:635-658.
- ECKLE T, Bertazzo J, Khatua TN, Fatemi Tabatabaei SR, et al
Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure.
Circ Res. 2024;134:675-694.
Circulation
- JUNCA G, Delgado V
Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
Circulation. 2024;149:822-824.
- HEUTS S, Myers PO, Siepe M
Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or
Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of
the FAME 3 Trial".
Circulation. 2024;149:892-893.
- RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI
or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up
of the FAME 3 Trial".
Circulation. 2024;149:894-895.
- ZIMMERMANN FM, Ding VY, Fearon WF
Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow
Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery
Disease: 3-Year Follow-Up of the FAME 3 Trial".
Circulation. 2024;149:896.
- HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell
Transplantation: From Pretransplantation to Survivorship: A Scientific Statement
From the American Heart Association.
Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
- GABA P, Sabik JF, Murphy SA, Bellavia A, et al
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in
Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled
Analysis of 4 Randomized Clinical Trials.
Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
Clin Cardiol
- LIU L, Du X, Wei X, Dong W, et al
The combination of high-frequency QRS and ST-segment alterations during exercise
stress tests enhanced the diagnostic efficacy for coronary artery disease.
Clin Cardiol. 2024;47:e24254.
- PAN Y, Wu TT, Deng CJ, Yang Y, et al
Smoking and outcomes following personalized antiplatelet therapy in chronic
coronary syndrome patients: A substudy from the randomized PATH-PCI trial.
Clin Cardiol. 2024;47:e24214.
Clin Chem
- DUGANI SB, Moorthy MV, Demler OV, Li C, et al
Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease
in Women.
Clin Chem. 2024 Mar 13:hvae007. doi: 10.1093.
Eur Heart J
- VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective
effects in experimental myocardial infarction.
Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
Heart
- CASTELIJNS MC, Hageman SHJ, Teraa M, van der Meer MG, et al
Generalisability of trials on antithrombotic treatment intensification in
patients with cardiovascular disease.
Heart. 2024;110:482-490.
- KITE TA, Ladwiniec A, Greenwood JP, Gale CP, et al
Very early invasive strategy in higher risk non-ST-elevation acute coronary
syndrome: the RAPID NSTEMI trial.
Heart. 2023 Dec 16:heartjnl-2023-323513. doi: 10.1136/heartjnl-2023-323513.
- MYRMEL GMS, Steiro OT, Tjora HL, Langorgen J, et al
Prognostic value of growth differentiation factor-15 3 months after an acute
chest pain admission.
Heart. 2024;110:508-516.
Int J Cardiol
- MCCORD J
Identification and definition of type 2 myocardial infarction: Where do we go
from here?
Int J Cardiol. 2024 Mar 7:131941. doi: 10.1016/j.ijcard.2024.131941.
- DE ALENCAR NETO JN, Scheffer MK, Correia BP, Franchini KG, et al
Systematic review and meta-analysis of diagnostic test accuracy of ST-segment
elevation for acute coronary occlusion.
Int J Cardiol. 2024;402:131889.
- OLSEN FJ, Smiseth OA, Biering-Sorensen T
Improving post-MI risk stratification with pressure-strain loops: Work in
progress.
Int J Cardiol. 2024;402:131866.
- DI VITO L, Di Giusto F, Grossi P
Non-culprit plaque progression: What do we know?
Int J Cardiol. 2024;402:131881.
- GHIZZONI G, Leone AM, di Serafino L, Galante D, et al
"The INOCA-IT: Rationale and design of a multicenter registry investigating
ischemia in patients with non-obstructive coronary artery (INOCA) disease in
Italy".
Int J Cardiol. 2024;402:131859.
- BOERHOUT CKM, Vink CEM, Lee JM, de Waard GA, et al
Impact of sex on the assessment of the microvascular resistance reserve.
Int J Cardiol. 2024 Feb 3:131832. doi: 10.1016/j.ijcard.2024.131832.
- AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse
event reporting system (FAERS).
Int J Cardiol. 2024;402:131819.
J Am Coll Cardiol
- BRIGUORI C, Quintavalle C, Mariano E, D'Agostino A, et al
Kidney Injury After Minimal Radiographic Contrast Administration in Patients With
Acute Coronary Syndromes.
J Am Coll Cardiol. 2024;83:1059-1069.
- KOSMIDOU I, Shahim B, Dressler O, Redfors B, et al
Incidence, Predictors, and Impact of Hospital Readmission After Revascularization
for Left Main Coronary Disease.
J Am Coll Cardiol. 2024;83:1073-1081.
- BATCHELOR WB, Damluji AA
Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
J Am Coll Cardiol. 2024;83:1082-1084.
J Clin Endocrinol Metab
- COSTA FC, Gomes LG, de Lima TM, Bortolotto LA, et al
Cardiovascular risk in women with nonclassical congenital adrenal hyperplasia.
J Clin Endocrinol Metab. 2024 Mar 11:dgae155. doi: 10.1210.
- STOKAR J, Szalat A
Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment:
a Propensity Score Matched Cohort Study.
J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210.
J Electrocardiol
- BELLFIELD RAA, Ortega-Martorell S, Lip GYH, Oxborough D, et al
Impact of ECG data format on the performance of machine learning models for the
prediction of myocardial infarction.
J Electrocardiol. 2024;84:17-26.
J Thorac Cardiovasc Surg
- GAUDINO M, Bairey Merz CN, Sandner S, Creber RM, et al
Randomized Comparison of the Outcome of Single Versus Multiple Arterial Grafts
trial (ROMA):Women-a trial dedicated to women to improve coronary bypass
outcomes.
J Thorac Cardiovasc Surg. 2024;167:1316-1321.
JAMA
- KO D, Pascual-Leone A, Shah SJ
Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of
Uncertainty.
JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2991.
- ANDERER S
Cannabis Use Linked to Elevated Myocardial Infarction and Stroke Risk.
JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2075.
N Engl J Med
- ROSWELL RO, Wong MP, Stefanescu Schmidt AC, Petranovic M, et al
Case 8-2024: A 55-Year-Old Man with Cardiac Arrest, Cardiogenic Shock, and
Hypoxemia.
N Engl J Med. 2024;390:1030-1043.
PLoS One
- ZUBERI S, Rafi H, Hussain A, Hashmi S, et al
Upregulation of Nrf2 in myocardial infarction and ischemia-reperfusion injury of
the heart.
PLoS One. 2024;19:e0299503.
- SCHON C, Felismino A, de Sa J, Corte R, et al
Correction: Efficacy of early cardiac rehabilitation after acute myocardial
infarction: Randomized clinical trial protocol.
PLoS One. 2024;19:e0300855.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016